Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Johnson & Johnson, which has been recalling a number of popular over-the-counter medicines, said Wednesday it’s withdrawing more Tylenol because of a labeling problem.
The company’s McNeil Consumer Healthcare unit is recalling nearly 9.3 million bottles of three Tylenol Cold Multi-Symptom products from drug stores and suppliers because the bottles’ front labels didn’t show they contain small amounts of alcohol from ingredients that flavor the medicine. Get the full story »
Johnson & Johnson is recalling yet another lot of over-the-counter Tylenol because of a musty or moldy smell. McNeil Consumer Healthcare business says it is recalling lot BCM155, or about 128,000 bottles, of Tylenol 8 Hour caplets that come in bottles with 50 pills. Get the full story »
U.S. health regulators knew that Johnson & Johnson’s McNeil unit was using a contractor to buy back potentially faulty batches of Motrin, though there was no formal agreement with the government, lawyers for the company told lawmakers.
Still, in a letter to the House Oversight and Government Reform Committee Wednesday, J&J’s lawyers said though the purchases of defective painkiller from retailers were legal, “moving forward the company would handle things differently.” Get the full story »
